Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The primary objective of this study will be to evaluate the efficacy of interleukin‐2 (IL‐2) as maintenance therapy in patients with acute myeloid leukaemia (AML) who have achieved first complete remission (CR).